English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 18 March 2016, 19:00 HKT/SGT
Share:
    

Source: Midas Holdings Limited
Midas Secures High-Speed and Metro Train Car Body Components Contracts Worth RMB247.7 Million in the PRC
- RMB217.3 million worth of orders for the supply of aluminium alloy extrusion profiles and fabricated parts for high-speed train cars
- RMB30.4 million contract for aluminium alloy extrusion profiles for the Shanghai Metro Line 17
- Contracts awarded by CRRC Changchun Railway Vehicles
- Orders slated for delivery in 2016

Singapore and Hong Kong, Mar 18, 2016 - (ACN Newswire) - Midas Holdings Limited ("Midas" or the "Company", together with its subsidiaries, the "Group"; SGXST stock code: 5EN; SEHK stock code: 1021) today announced that its subsidiary, Jilin Midas Aluminium Industries Co., Ltd ("Jilin Midas") has secured contracts totalling RMB247.7 million for the supply of train car body components for highspeed trains and metro trains.

The high-speed train contracts awarded, worth RMB217.3 million, are for the supply of aluminium alloy extrusion profiles and fabricated parts for two types of high-speed trains that will operate at speeds of up to 250km/h and 350km/h. Jilin Midas will also supply aluminium alloy extrusion profiles worth RMB30.4 million for the Shanghai Metro Line 17.

These contracts are awarded by CRRC Changchun Railway Vehicles Co., Ltd ("CRV") and are slated for delivery in 2016. The abovementioned contracts are expected to contribute positively to Midas' financial performance for the financial year ending December 31, 2016.

Mr. Patrick Chew, Executive Director and Chief Executive Officer of Midas, said, "We have been entrusted by CRV to deliver quality products that will be used in the manufacture of high-speed and metro train cars. Our success in maintaining close business relationships with top train manufacturers is the result of our comprehensive industry knowledge and strong track record. The latest set of contracts also reinforces our presence in China. Looking ahead, we will continue to build on relationships with our customers to boost our order book."

"We anticipate increased opportunities in the industry as the PRC government supports infrastructure development to improve trade relations with countries in Asia and Europe as part of its "One Belt, One Road" program and accelerates its participation in international rail projects. We are ready to take on new opportunities in both the PRC and international markets," added Mr. Chew.

About Midas Holdings Limited

Founded in 2000, Midas is the leading manufacturer of aluminium alloy extrusion products for the passenger rail transportation sector in the People's Republic of China (the "PRC") today. Over the years, Midas has built an established track record as a supplier of quality products to the PRC passenger rail transportation sector. It has participated in landmark contracts such as the Beijing-Tianjin High-Speed Train Project, and the CRH3-380 inter-city high-speed trains project. Midas' customers include major PRC train manufacturer CRRC Corporation Limited, and the three global train manufacturers - Alstom Transport, Siemens AG and Bombardier Transportation.

Midas has a strategic 32.5% stake investment in CRRC Nanjing Puzhen Rail Transport Co., Ltd. ("NPRT"), an associate company engaged in the development, manufacturing and sale of metro trains, bogies and their related parts.

In 2014, Midas won the 'Our Stars For Rail Systems 2014' award which was presented by Siemens' Rail Systems Division to its top global suppliers. Separately, Midas was also honoured with the 'Supplier of the Year Award' in 2012 by Bombardier Transportation.

The Company was also awarded the "Best Investor Relations Award (Gold)" at the Singapore Corporate Awards ("SCA") 2010 in the "S$300 million to less than S$1 billion market capitalisation" category. SCA also conferred the "Best CEO Award" and "Best CFO Award" to Midas' Chief Executive Officer, Mr. Patrick Chew, and Chief Financial Officer, Mr. Chan Chee Kin, in 2014 and 2015 respectively.

Midas has also won the "Most Transparent Company Award" (Chemical & Resources Category) at the Singapore Investors Association (Singapore) ("SIAS") Investors' Choice Awards for four consecutive years in 2012 to 2015.

As testament to its strong brand name and reputation in the PRC, Midas was conferred the prestigious "China Well-Known Trademark" by the Trademark Office of the State Administration for Industry & Commerce of the PRC ("SAIC") in 2011.

Midas has a primary listing on the Mainboard of the Singapore Exchange Securities Trading Limited and a secondary listing on the Main Board of the Stock Exchange of Hong Kong Limited. www.midas.com.sg

ISSUED ON BEHALF OF: Midas Holdings Limited
BY: Citigate Dewe Rogerson, i.MAGE Pte Ltd
55 Market Street
#02-01
SINGAPORE 048941

CONTACT:
Mr Ng Chung Keat / Ms Renee Goh
During office hours: +65-6534-5122 (Office)
After office hours: +65-9781-3605 / +65-9667-5837 (Handphone)
EMAIL: chungkeat.ng@citigatedrimage.com / renee.goh@citigatedrimage.com

Topic: Contract Awarded
Source: Midas Holdings Limited

Sectors: Daily Finance, Logistics & Supply Chain
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 26, 2024 23:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 26, 2024 22:25 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting  
Apr 26, 2024 13:16 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575